COVID‐19 is a respiration‐related disease caused by SARS‐CoV‐2 and was identified in
China's Wuhan city. More than 223 countries are affected by the disease worldwide. The …

COVID‐19‐related mortality in high‐risk individuals is substantial and current treatment
options are limited. There is convincing evidence that the COVID‐19 vaccines reduce the …

The development of effective assay techniques for severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has recently received research attention due to its rapid …

Virus infection has been one of the main causes of human death since the ancient times.
Even though more and more antiviral drugs have been approved in clinic, long-term use can …

In recent decades, biomedical sensors based on surface-enhanced Raman spectroscopy
(SERS), which reveals unique spectral features corresponding to individual molecular …

With the onset of the COVID-19 pandemic, enormous efforts have been made to understand
the genus SARS-CoV-2. Due to the high rate of global transmission, mutations in the viral …

We report the in vitro antiviral activity of DZNep (3-Deazaneplanocin A; an inhibitor of S-
adenosylmethionine-dependent methyltransferase) against SARS-CoV-2, besides …

Neutralizing antibodies (NAbs) can be indicators of collective immunity, vaccine efficacy,
and the longevity of the humoral response. This study aimed to compare reactogenicity and …

Numerous studies have led to a better understanding of the mechanisms of action of viruses
in systemic infections for the development of prevention strategies and very promising …

The COVID-19 pandemic over recent years has shown a great need for the rapid, low-cost,
and on-site detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In …